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Mouse hypoxia-inducible factor-1alpha is encoded by two
different mRNA isoforms: expression from a tissue-specific and
a housekeeping-type promoter
Abstract
Hypoxic induction of erythropoietin (Epo) and other oxygen-dependent genes is mediated by the
hypoxia-inducible factor-1 (HIF-1), a heterodimeric transactivator consisting of an alpha and a beta
subunit. We previously found that the mouse gene encoding HIF-1alpha harbors two alternative first
exons (I.1 and I.2), giving rise to two different HIF-1alpha mRNA isoforms. Here, we show by RNase
protection analysis that the exon I.1-derived mRNA isoform is differentially expressed in mouse tissues,
being highest in kidney, tongue, stomach, and testis, but undetectable in liver, whereas the exon I.2
mRNA isoform is ubiquitously expressed. Sequence and methylation analysis showed that, in contrast to
exon I.1, exon I.2 resides within a region showing typical features of a CpG island, known to be
associated with the 5' end of housekeeping genes. We identified a 232-bp minimal exon I.2 promoter
that strongly induced reporter gene expression in mouse L929 fibroblasts and Hepa1 hepatoma cells. In
contrast to L929 cells, the exon I.1 promoter was inactive in Hepa1 cells and hypoxic exposure (1% O2)
markedly reduced exon I.2 promoter activity in Hepa1 cells. Prolonged exposure of mice to hypoxia
(7.5% O2 for up to 72 hours) also caused a decrease in liver HIF-1alpha mRNA, whereas aldolase
mRNA levels increased. These findings might be related to the relatively low Epo levels in the adult
liver.
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Mouse Hypoxia-Inducible Factor-1a Is Encoded by Two Different mRNA
Isoforms: Expression From a Tissue-Specific and a Housekeeping-Type Promoter
By Roland H. Wenger, Andreas Rolfs, Patrick Spielmann, Dieter R. Zimmermann, and Max Gassmann
Hypoxic induction of erythropoietin (Epo) and other oxygen-
dependent genes is mediated by the hypoxia-inducible fac-
tor-1 (HIF-1), a heterodimeric transactivator consisting of an
a and a b subunit. We previously found that the mouse gene
encoding HIF-1a harbors two alternative first exons (I.1 and
I.2), giving rise to two different HIF-1a mRNA isoforms. Here,
we show by RNase protection analysis that the exon I.1-
derived mRNA isoform is differentially expressed in mouse
tissues, being highest in kidney, tongue, stomach, and testis,
but undetectable in liver, whereas the exon I.2 mRNA iso-
form is ubiquitously expressed. Sequence and methylation
analysis showed that, in contrast to exon I.1, exon I.2 resides
within a region showing typical features of a CpG island,
known to be associated with the 58 end of housekeeping
genes. We identified a 232-bp minimal exon I.2 promoter that
strongly induced reporter gene expression in mouse L929
fibroblasts and Hepa1 hepatoma cells. In contrast to L929
cells, the exon I.1 promoter was inactive in Hepa1 cells and
hypoxic exposure (1% O2) markedly reduced exon I.2 pro-
moter activity in Hepa1 cells. Prolonged exposure of mice to
hypoxia (7.5% O2 for up to 72 hours) also caused a decrease
in liver HIF-1a mRNA, whereas aldolase mRNA levels in-
creased. These findings might be related to the relatively low
Epo levels in the adult liver.
r 1998 by The American Society of Hematology.
STIMULATION OF ERYTHROPOIESIS during periods oflimited oxygen supply improves the oxygen transport
capacity of the blood. This physiologic adaptation to hypoxia is
regulated by the glycoprotein hormone erythropoietin (Epo)
that is mainly produced in the fetal liver and the adult kidney
(reviewed in Jelkmann1). Identification of a hypoxia-responsive
element in the 38 flanking region of the gene encoding Epo led
to the discovery of the hypoxia-inducible factor-1a (HIF-1a).2
HIF-1a is a basic-helix-loop-helix (bHLH) transcription factor
that is activated by exposure of cells to physiologically relevant
reductions in oxygen partial pressure (reviewed in Bunn and
Poyton,3 Wenger and Gassmann4). This activation involves
hypoxic stabilization of the protein that is otherwise ubiquiti-
nated and rapidly degraded in proteasomes under normoxic
conditions.5-8 Moreover, the activity of the transactivation
domain(s) can also be hypoxically induced.6,9,10 So far, the
mechanisms leading to these hypoxic effects are not clearly
understood, but there is evidence that redox processes,5,8,11 as
well as phosphorylation,12,13 might be involved. After hypoxic
exposure, HIF-1a forms a heterodimeric complex with the aryl
hydrocarbon receptor nuclear translocator (ARNT), also termed
HIF-1b, which activates expression of oxygen-dependent
genes.3,4 These oxy-genes4 include Epo, transferrin, vascular
endothelial growth factor, glycolytic enzymes, inducible nitric
oxide synthase, heme oxygenase, as well as other genes
involved in the adaptation of an organism to reduced oxygen-
ation at the cellular, local, and systemic level. ARNT also serves
as a heterodimerization partner for the aryl hydrocarbon recep-
tor (AhR), also called dioxin receptor, which activates genes
involved in xenobiotic metabolism such as the gene encoding
cytochrome P450IA1. Besides the common bHLH DNA bind-
ing and heterodimerization domain, all of these factors contain a
region of amino acid similarity termed PAS (PAS is an acronym
for the first described members of this family, namely Per,
ARNT, and Sim).4
We previously cloned and characterized the gene encoding
mouse HIF-1a (Hif1a) and showed that it contains two different
first exons (termed I.1 and I.2).14 Expression of these two mouse
HIF-1a mRNA transcripts is regulated by distinct promoters
rather than being the product of differential splicing. The two
alternative first exons give rise to two distinct mRNA isoforms
differing in the composition of their 58 untranslated regions
(UTRs). Moreover, the predicted translation product derived
from the exon I.1-containing mRNA isoform is 12 amino acids
shorter than the exon I.2-containing isoform. These findings
raised the possibilities of differential translational regulation
and/or different protein functions.14 So far, no human HIF-1a
mRNA isoform has been detected that corresponds to mouse
exon I.1. We also analyzed the Hif1a exon I.1 promoter and
found that it is only moderately active in the cell lines tested,
suggesting that additional cis-regulatory elements and/or so far
unknown activators (eg, developmental-stage, tissue-specific,
or conditional signals) are required for efficient exon I.1
promoter activity.14
Here, we present the sequence analysis, as well as the
structural and functional characterization, of Hif1a exon I.2 and
flanking regions. In addition, we examined the expression
profile of both mRNA isoforms in various adult mouse tissues.
Our results suggest that Hif1a exon I.1 regulation exhibits
tissue-specific features, whereas the exon I.2 promoter re-
sembles a housekeeping-type promoter.
MATERIALS AND METHODS
Reverse transcription-polymerase chain reaction (RT-PCR) analysis.
Total RNA was isolated from mouse tissues according to the method
described by Chomczynski and Sacchi.15 Expression of the two mouse
HIF-1a mRNA isoforms was examined as described.14 Briefly, each 2.5
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µg of total RNA was reverse transcribed, and equal aliquots of the
cDNA were amplified by PCR using specific forward primers for either
exon I.1 or exon I.2 and an exon III reverse primer. Equal fractions of
the reaction mixes were electrophoresed through 1% agarose gels.
Ethidium bromide-stained gels were recorded using a video imaging
system (Vilber Lourmat, Inotech, Dottikon, Switzerland).
RNase protection assay. Hif1a exon I.1 and exon I.2 DNA frag-
ments were subcloned in pBluescript (Stratagene, La Jolla, CA) and
antisense cRNA probes were obtained by in vitro transcription with T7
RNA polymerase (MBI Fermentas, Vilinius, Lithuania) in the presence
of a 32P-uridine triphosphate (UTP). After purification by denaturing
urea/polyacrylamide gel electrophoresis, the probes were hybridized
with 50 µg total RNA and digested with RNase A and RNase T1
according to the manufacturer’s directions (RPA-II Kit; Ambion,
Austin, TX). Protected products were resolved by nondenaturing 5%
polyacrylamide gel electrophoresis. Radioactive signals were recorded
and quantified by phosphorimaging (Molecular Dynamics, Sunnyvale,
CA), and the images were displayed using a linear relationship between
signal and image intensity. A mouse b-actin probe (Ambion) was used
to control for equal RNA amounts between the different samples. These
reactions were performed using 2 µg total RNA only.
Cloning and sequencing. The exon I.2-containing l phage clone
lH30 was cloned from a LambdaGEM-11 (Promega, Madison, WI)
genomic library as described previously.14 A 270-bp EcoRI-NcoI (all
restriction enzymes were purchased from Fermentas) cDNA fragment
containing mouse exon I.2 sequences (kindly provided by A. Damert,
Bad Nauheim, Germany) served as hybridization probe. A 2.9-kb XbaI
fragment from lH30, containing exon I.2 and flanking sequences, was
subcloned into pBluescript SK1 yielding the plasmid pH30X. The insert
of this plasmid was sequenced on both strands using a combination of
automated and manual sequencing procedures with fluorescently la-
beled dideoxynucleotides or a 35S-deoxy adenosine triphosphate (dATP)
incorporation in cycle sequencing reactions and T7 sequencing reac-
tions, respectively, according to the instructions provided by the manufactur-
ers (Applied Biosystems, Foster City, CA and Pharmacia, Uppsala, Sweden).
Sequence analysis was performed using the GCG program package16 or the
DNASIS for Windows program (Hitachi, Tokyo, Japan).
Cell culture. The mouse hepatoma cell line Hepa1 (also termed
Hepa1c1c7)17 was a kind gift of L. Poellinger (Huddinge, Sweden). The
mouse fibroblast cell line L929 (American Type Culture Collection,
Rockville, MD, CCL-1 NCTC clone 929) was a kind gift of V.
O’Donnall (Bern, Switzerland). Both cell lines were cultured in
Dulbecco’s modified Eagle’s medium (DMEM, high glucose; Life
Technologies, Basel, Switzerland) supplemented with 10% heat-
inactivated fetal calf serum (Boehringer, Mannheim, Germany), 100
U/mL penicillin, 100 µg/mL streptomycin, 1 3 nonessential amino
acids, 2 mmol/L L-glutamine, and 1 mmol/L Na-pyruvate (all purchased
from Life Technologies) in a humidified atmosphere containing 5% CO2
at 37°C. Oxygen tensions in the incubator (Forma Scientific, model
3319; Bioblock, Frenkendorf, Switzerland) were either 140 mm Hg
(20% O2 vol/vol, normoxia) or 7 mm Hg (1% O2 vol/vol, hypoxia).
Mapping of the exon I.2 transcription initiation site. The cap site of
the mouse HIF-1a exon I.2-containing mRNA was determined by
primer extension and mung bean nuclease protection. For primer
extension, the oligonucleotide mHIFpex2 (see Fig 2) was radioactively
labeled by phosphorylation of the 58 end with [g-32P]ATP (Hartmann
Analytik, Braunschweig, Germany) and T4 polynucleotide kinase
(Fermentas) as described previously.18 Total RNA was extracted from
mouse Hepa1 hepatoma cells according to Chomczynski and Sacchi.15
Poly(A)1 RNA was prepared using oligo dT cellulose spin columns
according to the manufacturer’s instructions (Pharmacia). Endlabeled
mHIFpex2 (0.4 pmol) was coprecipitated with 5 µg poly(A)1 RNA and
resuspended in 10 µL 0.4 mol/L NaCl, 10 mmol/L Pipes [pH 6.4] at
96°C for 2 minutes. After annealing at 56°C for 10 minutes and at room
temperature for 15 minutes, primer extension was performed in 50 µL
RT buffer (Stratagene), 1 U/µL ribonuclease inhibitor (RNasin, Pro-
mega), 0.5 mmol/L deoxynucleotide triphosphates (dNTPs; Promega)
containing 250 U reverse transcriptase (Stratascript, Stratagene) at 42°C
for 2 hours. The reaction products were ethanol precipitated, resus-
pended in 50% formamide, electrophoresed through a 6% polyacryl-
amide/urea sequencing gel, and visualized by autoradiography. A T7
polymerase sequencing reaction, performed with the primer mHIFpex2
and pH30X single-stranded DNA according to the manufacturer’s
instructions (Pharmacia), served as position marker.
Mung bean nuclease protection was performed essentially as de-
scribed before.14 Briefly, single-stranded DNA from the plasmid pH30X
was prepared using M13K07 helper phages. The 58 endlabeled mHIF-
pex2 oligonucleotide was annealed to the template DNA and extended
using Klenow fragment of DNA polymerase I (Fermentas). After
cleaveage with PvuII, the single-stranded antisense probe was prepared
by alkaline agarose gel electrophoresis. This probe (100 kcpm) was
hybridized to 50 µg total RNA isolated from Hepa1 cells and digested
with 0, 10, 30, or 90 U mung bean nuclease (Life Technologies) for 30
minutes at 30°C. The products were analyzed on a sequencing gel as
described above using an unrelated sequencing reaction as length marker.
In vivo methylation analysis. To isolate genomic DNA, cell lines
and mouse tissues were homogenized in 0.2 mol/L NaCl, 50 mmol/L
Tris-HCl [pH 8.0], 10 mmol/L EDTA, 1% sodium dodecyl sulfate
(SDS), and digested with 0.5 mg/mL Proteinase K (Boehringer Mann-
heim) at 60°C for 12 hours. After addition of 0.2 mL saturated NaCl and
microcentrifugation, the DNA was precipitated from the supernatant by
adding 0.45 mL isopropanol. The DNA was resuspended in 10 mmol/L
Tris-HCl [pH 7.6], 1 mmol/L EDTA, and cleaved with XbaI, either
alone or in combination with Cfr42I, SmaI, NotI, HhaI, HpaII, or MspI.
After gel electrophoresis through a 0.7% agarose gel, the DNA was
transferred to uncharged Biodyne A membranes (Pall Filtron, Northbor-
ough, UK) and cross-linked by ultraviolet irradiation (Stratalinker;
Stratagene). The membrane was hybridized to a 561-bp Bsp1407I-
BstEII fragment derived from pH30X as described previously.14 The
signals were recorded by phosphorimaging.
Reporter gene assays. A firefly luciferase reporter gene construct
(pHXN1aluc) containing exon I.2 upstream regulatory regions was
obtained by inserting a 1.5-kb KpnI 2 NheI fragment (KpnI cuts in the
polylinker 58 to the XbaI site shown in Fig 2) into the promoterless
luciferase vector pGL3Basic (Promega). Three deletion constructs were
made using BspTI, Eco91I, and PvuII, which cleaved 801, 613, and 232
bp, respectively, upstream of the first transcription initiation site. A
similar reporter gene construct containing 499 bp of exon I.1 upstream
regulatory sequences (pGL499Luc) was described previously.14 Tissue
culture cells (1 3 107 in 350 µL medium without fetal calf serum) were
coelectroporated with each 25 µg luciferase reporter gene construct and
a b-galactosidase reference vector as described previously.14 After
incubation for 24 to 38 hours, the cells were lysed in reporter lysis
buffer (Promega) and luciferase and b-galactosidase activities were
determined according to the manufacturer’s instructions (Promega)
using a Lumat LB9501 luminometer (Berthold, Bad Wildbad, Ger-
many) and a DigiScan 96-well plate photometer (ASYS, Eugendorf,
Austria), respectively. Differences in the transfection efficiency and
extract preparation were corrected by normalization to the correspond-
ing b-galactosidase activities.
Hypoxic exposure of mice. Animals were exposed to a gas mixture
containing 35% air and 65% N2 (7.5% O2 final concentration) in an
airtight chamber containing water and nutrients ad libidum. After
exposure, the mice were killed by cervical dislocation and the organs
were withdrawn and frozen in liquid N2. Liver RNA was extracted and
analyzed by Northern blotting as described previously.19 The filters
were subsequently hybridized with probes for mouse HIF-1a,20 aldol-
ase A,19 and ribosomal protein L28,19 the latter used to normalize for
differences in loading and blotting efficiency.
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RESULTS
Differential tissue expression of the two mouse HIF-1a
mRNA isoforms. We previously reported that the two mRNA
isoforms coding for HIF-1a are coexpressed in L929 and Hepa1
mouse cell lines.14 Here, we examined the expression pattern of
the two HIF-1a mRNAs in several mouse tissues. To distin-
guish between the two isoforms, RT-PCR reactions were
performed using primers specific for either exon I.1 or exon I.2
in combination with an exon III primer. As shown in Fig 1, this
yielded specific PCR products of 371 bp and 472 bp for exon I.1
and exon I.2, respectively. The specificity of these products was
further confirmed by restriction digestions and Southern blot-
ting (data not shown). Interestingly, while the exon I.2 mRNA
isoform was ubiquitously expressed with less than fourfold
variation in signal intensity between the different tissues, the
exon I.1 mRNA isoform showed a distinct expression pattern.
Exon I.1 mRNA levels were highest in kidney, spleen, thymus,
tongue, and the reproductive organs (testis, ovary, and uterus);
moderate in brain, heart, lung, bone marrow, and skeletal
muscle; and no exon I.1 mRNA isoform could be detected in
any liver of five mice analyzed. Exposure of the mice to 0.1%
carbon monoxide for 4 hours, causing functional anemia,21 did
not significantly alter the expression pattern of the two HIF-1a
mRNA isoforms (data not shown), whereas Epo mRNA in
kidney and liver was increased under the same conditions.21 In
agreement with our previous observations using various cell
lines,14 the present RT-PCR analysis of mouse tissues did not
yield any evidence for the existence of an mRNA isoform
containing exon I.2 as an alternative splice variant, further
supporting the notion that two independent promoters drive
expression of the two alternative first exons.
Due to the distinct base compositions and lengths of exons I.1
and I.2, this RT-PCR approach did not allow to determine the
relative expression levels of the two mouse HIF-1a mRNA
isoforms. To circumvent this problem, an RNase protection
assay was established using labeled antisense probes specific
for exons I.1 and I.2, respectively (Fig 2). RNase protection
showed that the exon I.1 mRNA isoform was detectable only in
kidney, tongue, testis, stomach, and embryonic tissue (embry-
onic day E18.5). Interestingly, whereas the previously mapped14
113-bp protected fragment represented the sole exon I.1 mRNA
species in Hepa1 cells, an additional mRNA species might exist
in mouse tissues whose 58 end probably extends the length of
the 134 nt cRNA probe (Fig 2), indicating that a second
transcriptional start site might exist in mouse tissues upstream
to that mapped in Hepa1 cells. In contrast to the exon
I.1-derived mRNA isoform, the I.2 isoform was ubiquitously
expressed. Taking into consideration the differences in probe
length, the exon I.2 mRNA isoform was estimated to be at least
sevenfold more abundant (testis) than the exon I.1 mRNA
isoform.
DNA sequence of mouse Hif1a exon I.2 and flanking regions.
The ubiquitous expression of the exon I.2-derived HIF-1a
mRNA isoform implied that, unlike exon I.1, exon I.2 is
expressed from a housekeeping-type promoter. To test this
hypothesis directly, we subcloned and sequenced exon I.2 and
flanking regions (Fig 3) using the previously isolated l phage
lH30 that bridged the gap between exon I.1 and exon III-
containing phage clones.14 Exon I.2 was 96.8% identical to the
corresponding sequence of the mouse HIF-1a cDNA 58 end
reported by Li et al,9 containing three mismatches and seven
insertions. In contrast to exon I.1, exon I.2 had an ATG
translation initiation codon in frame with the ATG on exon II,
leading to a predicted translation product that was 12 amino
acids longer than the one derived from the exon I.1 mRNA
isoform (Fig 3). These 12 N-terminal amino acids were
identical to those predicted from the cDNA reported by Li et al.9
The observed translation initiation site (TTCGCCATGG)
matched the consensus reported by Kozak (GCCRCCATGG).22
Furthermore, the exon-intron splice junction conformed to the
consensus sequence.23
Exon I.2 was 75% identical to the 58 UTR of the human
HIF-1a cDNA and the predicted amino acid sequence differed
in two of the 12 positions (Glu7 to Ala and Glu9 to Asp). Thus,
exon I.2 encoded the mouse homologue of the human HIF-1a
58 end. On the other hand, no human homologue for exon I.1
has been reported so far. Because the in-frame ATG codon on
the second exon of mouse Hif1a is not present in the human
gene, we consider that a putative human homologue would
contain the ATG initiation codon on the alternative first exon
rather than on the second exon. Alternatively, a human homo-
logue of mouse exon I.1 might not exist.
Fig 1. Hif1a exon I.1 and exon I.2-containing mRNA isoforms are detectable in most mouse tissues. RT-PCR analysis of total RNA isolated from
the indicated mouse tissue. PCR was performed using forward primers unique to either exon I.1 or exon I.2 and a common reverse primer specific
for exon III. Single PCR products were indicative for the exon I.1 (371 bp) or the exon I.2 (472 bp) mRNA isoform. Representative results of two to
five independent experiments are shown. Note that the exon I.1 mRNA isoform could not be detected in liver.
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Mapping of the transcription initiation site of Hif1a exon I.2.
To determine the cap site of the HIF-1a exon I.2 mRNA
isoform, primer extension analysis was performed using
poly(A)1 RNA isolated from mouse Hepa1 hepatoma cells
primed with the exon I.2-specific oligonucleotide mHIFpex2
(see Fig 3). As depicted in Fig 4, two major bands were
obtained, corresponding to C1390 and C1397 of the sequence
shown in Fig 3. To confirm this result, we also applied a
nuclease protection assay using an endlabeled antisense DNA
probe and total Hepa1 RNA. After hybridization of the probe to
the RNA, increasing amounts of mung bean nuclease were
added to digest protruding ends of the DNA-RNA hybrids, as
well as excess single-stranded antisense probe. In this case, two
major bands were identified corresponding to C1390 and C1395
(Fig 3). Thus, the longest Hif1a exon I.2-derived transcription
product was 325 bp (corresponding to a 58 UTR of 290 bp),
which was 16 bp longer than the cDNA reported by Li et al.9 All
three start sites (indicated by arrowheads in Fig 3) conformed to
the CA rule for eukaryotic transcription initiation sites.24,25
However, as reported by these investigators, the preferred cap
site corresponds to an adenosine rather than to a cytosine. The
reason for this discrepancy is currently unknown, but might be
related to the lack of a canonical TATA box, known to be
associated with multiple transcriptional start sites.
Hif1a exon I.2 is located within an essentially methylation-
free CpG island. One intriguing feature of mouse Hif1a exon
I.2 was the finding that it is located within a G1C rich region.
Figure 5 shows a comparison of the G1C content of the exon
I.1 and I.2 loci. Whereas the exon I.1 locus displayed an average
G1C content of approximately 43%, comparable to that of the
bulk genome, exon I.2 and upstream regions had a G1C content
of 76%. After a short oligo T repeat at the beginning of intron 1
(Fig 3), a second G1C rich (81%) stretch was found. Because
G1C rich regions associated with 58 ends of genes are
indicative for the presence of methylation-free CpG islands
(reviewed in Cross and Bird,26 Gardiner-Garden and From-
mer27), we analyzed the frequency of CpG dinucleotides, as
well as the in vivo CpG methylation pattern.
CpG dinucleotide frequencies are usually estimated as the
ratio of CpG (ie, observed) versus GpC (ie, expected) over a
certain nucleotide region. As shown in Fig 5A, the occurrence
of the CpG dinucleotide was suppressed in the exon I.1 locus
(CpG to GpC ratio of 0.3). By contrast, the frequency of the
Fig 2. Relative expression levels of Hif1a exon I.1 and exon I.2-containing mRNA isoforms in various mouse tissues. RNase protection assays
using each 50 mg total RNA and exon I.1 and I.2-specific antisense probes. A total of 2 mg total RNA was used for the b-actin control reactions.
Besides the sole protected 113-bp fragment in Hepa1 cells, a second mRNA species appeared in mouse tissues probably exceeding the 58 end of
the exon I.1 probe (134 nt).
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CpG dinucleotide in the G1C rich exon I.2 locus was similar to
the GpC frequency (Fig 5B).
CpG methylation was assessed in several mouse cell lines
and tissues by Southern blotting using CpG methylation-
sensitive restriction enzymes. As shown in Fig 6A, genomic
DNA was cleaved with XbaI, either alone or in combination
with a second enzyme recognizing selected sites in exon I.2 or
in the 58 and 38 flanking regions. A 561-bp 58 fragment derived
from a region outside of the G1C rich CpG island served as
hybridization probe. As shown in Fig 6B, the SmaI site in exon
I.2 and the NotI site in the downstream region were entirely
methylation-free. Interestingly, methylation of the Cfr42I site in
the upstream region was about 50% in all cell lines and tissues
tested. To date, we have no conclusive explanation for this
result, but it might be related to the observation of Matsuo et
al,28 who showed that the mouse experiences more accidental
CpG island methylation than man, resulting in erosion of mouse
CpG islands during evolution. Because this feature was rather
unexpected for a CpG island-type promoter, we further ana-
lyzed the 58 region using the CpG methylation-sensitive restric-
tion enzymes HhaI and HpaII together with the methylation-
insensitive HpaII-isoschizomer MspI. As shown in Fig 6C, the
upstream CpG dinucleotides of the G1C rich region were
methylation-free, whereas one CpG outside of the CpG island
was mostly methylated. Of note, an HpaII/MspI restriction
fragment length polymorphism was detected in these experi-
ments (Fig 6C). Taken together, the exon I.2 locus fulfills the
criteria for a CpG island, as it is G1C rich, shows unsuppressed
CpG frequency, and is essentially CpG methylation-free.
As often observed in CpG islands, we noted the lack of a
canonical TATA box and a high number of putative Sp1 binding
sites (Fig 3). It has been reported that Sp1 binding is implicated
in maintaining CpG islands methylation-free.26 Furthermore,
two putative HIF-1a binding sites were identified, which
perfectly matched the consensus sequence we reported previ-
ously.4 However, because HIF-1a mRNA levels in cell lines29
and mice20 were not upregulated by hypoxia, these putative sites
are probably not functional. Notably, also a putative HIF-1
binding site in the exon I.1 promoter was found to be
nonfunctional.14
Comparison of the Hif1a exon I.1 and I.2 promoter activities.
To analyze the presumed exon I.2 promoter activity, a 1.4-kb
fragment of the exon I.2 upstream region was inserted into a
promoterless firefly luciferase reporter gene vector. To directly
compare the respective promoter activities of exon I.1 and exon
I.2 upstream sequences, a 499-bp exon I.1 promoter-containing
luciferase construct was also analyzed. As reported previ-
ously,14 the exon I.1 promoter activity using either a 0.5-kb or a
1.0-kb fragment was about equal. Mouse L929 fibroblasts and
Hepa1 hepatoma cells were transiently transfected with both
constructs and incubated for 24 to 28 hours at normoxic
conditions. A cotransfected b-galactosidase expression vector
served as a reference to correct for differences in transfection
efficiency and extract preparation. As shown in Fig 7, the exon
I.2 promoter construct was 10-fold and fivefold more active
than the exon I.1 promoter construct in L929 and Hepa1 cells,
respectively. Interestingly, while in these experiments the exon
I.1 promoter stimulated basal luciferase expression ninefold in
L929 fibroblasts, only very low promoter activity could be
detected in Hepa1 hepatoma cells, suggesting that the exon I.1
Fig 3. Hif1a exon I.2 and flank-
ing regions. The sequence of
exon I.2 is in bold, repetitive ele-
ments and restriction enzyme
recognition sites are underlined,
and putative transcription factor
consensus binding sites are
double underlined. The transcrip-
tion initiation sites mapped by
primer extension and mung bean
nuclease protection (see Fig 4)
are indicated by filled arrows and
the start of intron 1 by an open
arrow. The predicted translation
initiation codon and the first 12
amino acids of the exon I.2 iso-
form are indicated. The location
of the oligonucleotide mHIFpex2
is depicted with a line over the
sequence.
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promoter was not active in hepatoma cells. This finding is in
line with the lack of detectable exon I.1 mRNA isoform
expression in mouse liver (see above).
Hypoxia decreases Hif1a exon I.2 promoter activity in mouse
hepatoma cells. To further analyze the exon I.2 promoter,
several deletion constructs were prepared containing 1389, 801,
613, or 232 bp of exon I.2 upstream regulatory sequences. After
transient transfection, L929 and Hepa1 cells were split and
exposed to normoxia (20% O2) or hypoxia (1% O2) for 36 to 38
hours. As shown in Fig 8, deletion of most of the 1389-bp
fragment only marginally reduced exon I.2 promoter activity in
normoxic cells, and the 232-bp fragment was almost equally
active as the 1389-bp fragment. Interestingly, exposure of the
cells to 1% oxygen reduced luciferase expression about fivefold
in Hepa1 cells, but only marginally in L929 cells. Conversely,
parallel transfections with an SV40 promoter-driven luciferase
vector containing three concatamerized Epo-derived HIF-1
binding sites17,18,30 showed about twofold hypoxic induction
(data not shown). These results imply that the previously
observed17,30 time-dependent hypoxic decrease in HIF-1a steady-
state mRNA levels in Hepa1 cells is due to a concomitant
reduction in exon I.2 promoter activity.
Hypoxic reduction of HIF-1a mRNA in mouse liver. The
hypoxic decrease of exon I.2 mRNA levels and promoter
activity in mouse hepatoma cells and the lack of the exon I.1
mRNA expression in mouse liver implied that chronic hypoxia
might result in reduced hepatic HIF-1a mRNA levels. To test
this hypothesis, mice were exposed in triplicates to hypoxic
hypoxia (7.5% O2) for up to 3 days. After exposure, liver RNA
was isolated and analyzed by Northern blotting. Figure 9
depicts the ratio between HIF-1a mRNA and the ribosomal
protein L28 mRNA, which was used to normalize for differ-
ences in loading and blotting efficiency. Interestingly, the HIF-a
to L28 ratio slightly decreased in hypoxic mouse liver by 20%
to 30%, whereas the hypoxia-inducible glycolytic enzyme
aldolase A mRNA to L28 ration transiently increased 2.2-fold
after 24 hours and decreased again to 1.6-fold over normoxic
controls after 48 to 72 hours.
DISCUSSION
In this work, we showed that the mouse HIF-1a exon
I.1-containing mRNA isoform is tissue-specifically expressed,
whereas the exon I.2 isoform displays an ubiquitous expression
pattern in all mouse tissues examined. Ubiquitous HIF-1a
Fig 5. Hif1a exon I.2 is located within a CpG island. G1C content
across the exon I.1 (A) and exon I.2 (B) regions. A window of 100 bp
shifted in steps of 1 bp was used in the computer-assisted analysis.
The positions of exon I.1 and exon I.2 are indicated. The CpG/GpC
ratio is given for each DNA segment that could be distinguished from
adjacent segments by the difference in the G1C content.
Fig 4. Mapping of the Hif1a exon I.2 transcription initiation sites.
(A) Primer extension. Poly(A)1 mRNA was isolated from mouse
Hepa1 cells and annealed to the endlabeled, complementary oligo-
nucleotide mHIFpex2 (see Fig 3). The primer was extended with
reverse transcriptase and the products were resolved on a 6%
denaturing polyacrylamide gel together with a sequencing reaction
performed with the same oligonucleotide as primer and a plasmid
containing the sequence shown in Fig 3 as template. (B) Nuclease
protection. Total RNA derived from Hepa1 cells was hybridized to an
endlabeled single-stranded antisense probe prepared as described in
Materials and Methods. The DNA-RNA hybrids were treated with the
indicated amounts of mung bean nuclease and separated on a
sequencing gel along with an unrelated sequencing ladder that
served as length marker. Numbers indicate the lengths of reaction
products including the mHIFpex2 primer.
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Fig 6. Methylation pattern of the Hif1a exon I.2 region. (A) Map of
the CpG methylation-sensitive restriction enzyme recognition sites
selected to assess the methylation pattern of distinct CpG dinucleo-
tides in the exon I.2 region. The methylation status of a particular
restriction enzyme site is indicated by open and partially filled circles.
(B) Southern blot analysis of genomic DNA isolated from various
mouse cell lines and tissues. The DNA was cleaved either with XbaI
alone, or in combination with CpG methylation-sensitive restriction
enzymes cutting 58 (Cfr42I, C), within (SmaI, S), or 38 (NotI, N) of exon
I.2. (C) Detailed exon I.2 upstream Southern blot analysis using the CpG
methylation-sensitive restriction enzymes Cfr42I (C), HhaI (H) and HpaII
(P), or the methylation-insensitive HpaII-isoschizomer MspI (M). Note
that an HpaII/MspI restriction fragment length polymorphism (RFLP)
was detected.
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expression correlates with the previous observation that HIF-1
DNA binding activity and HIF-1–mediated transactivation of
reporter genes is widespread in mammalian cells.31,32 We
sequenced and functionally characterized the alternative mouse
Hif1a exon I.2 and 58 flanking regions that we previously
mapped approximately 6 kb downstream of the Hif1a exon
I.1.14 As predicted from the G1C rich 58 UTR of human and
mouse HIF-1a mRNA,14 exon I.2 is located within a 1.3-kb
G1C rich, mostly methylation-free CpG island, known to be
associated with the promoters of housekeeping genes. This
observation is in agreement with the ubiquitous expression of
the exon I.2 mRNA isoform. However, because about 40% of
all tissue-specifically expressed genes also contain CpG island-
type promoters,26,27 we cannot exclude the possibility that the
Hif1a exon I.2 promoter works in a cell type-specific manner in
vivo. The RT-PCR and RNase protection approaches used in
this work were not suitable to identify the cell type expressing a
particular mRNA. Even if the exon I.2 promoter is ubiquitously
active in cell culture, in situ hybridization experiments of mouse
tissues will be necessary to unambigously determine the HIF-1a
mRNA levels in a particular cell type. In view of the fact that
Fig 8. Hypoxic downregulation of Hif1a exon I.2 promoter activity.
Exon I.2 upstream sequences of various length as indicated were
placed in front of the firefly luciferase reporter gene. These constructs
were transiently transfected into mouse L929 fibroblasts or Hepa1
hepatoma cells, followed by exposure to normoxia or hypoxia for 36
to 38 hours. Subsequently, luciferase expression was determined as
described in Fig 7. All values were normalized to the respective
normoxic luciferase activity obtained with the construct containing
the longest 58 region, which was arbitrarily defined as 100. Mean 6
SD of three independent experiments are shown.
Fig 9. Hypoxic reduction of HIF-1a mRNA levels in mouse liver.
Three mice each were exposed to 7.5% O2 for 0 to 72 hours and liver
RNA was analyzed by Northern blotting. Shown are the ratios of
HIF-1a mRNA and aldolase A mRNA, respectively, and the ribosomal
protein L28 mRNA (mean 6 SD).
Fig 7. Comparison of the Hif1a exon I.1 and exon I.2 promoter
activities. The empty parental vector pGL3Basic or the same vector
containing either the exon I.1 promoter or the exon I.2 promoter were
transiently transfected into mouse L929 fibroblast and Hepa1 hepa-
toma cells. Luciferase activity was determined after 24 to 28 hours of
normoxic incubation. A cotransfected b-galactosidase expression
vector served as internal control for transfection efficiency and
extract preparation. All values were normalized to the respective
luciferase activity obtained with the empty vector pGL3Basic, which
was arbitrarily defined as 1. Mean 6 standard deviation (SD) of three
independent experiments are shown. Note the different scales.
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adaptation to different oxygenation is likely to be mandatory for
every single cell, a tissue-specific HIF-1 expression seems to be
rather improbable. However, tissue-specific expression of the alterna-
tive mouse HIF-1a mRNA isoforms, as well as the recently
discovered hypoxia-inducible HIF-2a4 (also termed EPAS1,33 HLF,34
or HRF35) might complement each other to ensure ubiquitous
HIF-1–like activity. Of note, also two tissue- and developmental
stage–specifically expressed ARNT relatives (ARNT236,37 and
BMAL138), as well as several other bHLH-PAS proteins, have
recently been detected, implying a complex network of spatial and
temporal formation of heterodimeric bHLH-PAS transcription fac-
tors.
A remarkable finding of our HIF-1a mRNA expression
analysis in various mouse tissues is the lack of detectable exon
I.1 mRNA isoform and a slight hypoxic reduction of the exon
I.2 mRNA isoform in mouse liver. In mouse Hepa1 hepatoma
cells in culture, reporter gene experiments showed that the
Hif1a exon I.1 promoter is inactive and hypoxic exposure
reduced exon I.2 promoter activity. These data are consistent
with our previous finding that hypoxia time-dependently de-
creases HIF-1a (but not ARNT) mRNA levels in Hepa1
cells,17,30 and they might also explain why reporter gene
experiments using hypoxia-responsive luciferase constructs
consistently gave lower induction levels in Hepa1 cells than in
other cell lines.18,30,39 Both promoters were much more active in
L929 cells compared with Hepa1 cells and the hypoxic down-
regulation could neither be found in L929 nor in any other
human hepatoma (Hep3B and HepG2) or nonhepatoma cell line
examined (unpublished observation, June 1997).
Overall, our in vitro data provide an explanation for the in
vivo findings and it is tempting to speculate that altered HIF-1a
mRNA levels might also influence target gene expression. For
example, endogenous transferrin mRNA was less induced by
hypoxia in Hepa1 compared with the human hepatoma cell lines
Hep3B and HepG2,40 and oxygen-regulated Epo expression is
also exclusively found in Hep3B and HepG2,3 but was undetect-
able in Hepa1 cells (our unpublished observations, August
1995). One hallmark of Epo expression is the switch during
development from the fetal liver to the adult kidney as the main
source of Epo synthesis. In mammals, this switch takes place in
the third trimester of gestation.1 However, the molecular
mechanism(s) underlying this phenomenon are currently un-
known. At least in the adult mouse, our results on HIF-1a
mRNA expression might provide a (partial) explanation of why
hypoxia-dependent Epo production is lowered in the adult liver.
Clearly, examination of HIF-1a mRNA isoform expression in
murine liver and kidney during development will be required to
elucidate a possible role of HIF-1 in tissue-specific and
developmental stage–specific Epo expression.
The kinetics of hypoxic HIF-1 protein activation appears
different from that of HIF-1a mRNA downregulation in Hepa1
cells. Four hours of 1% oxygen are sufficient to induce HIF-1
DNA binding activity in Hepa1 cells.17,29,30 Four hours of 0.1%
carbon monoxide treatment are also typically used to elicit a
hypoxic response in mice.21 However, 4 hours of hypoxia does
not alter expression of the two HIF-1a mRNA isoforms in
Hepa1 cells17,29,30 or in mice,20 but rather, at least 8 hours
hypoxia are required to downregulate HIF-1a mRNA in Hepa1
cells.17,30 For transient expression experiments, we typically
induced the cells for 36 to 38 hours, and 24 hours of hypoxic
exposure was also necessary to see a change in mouse liver
HIF-1a mRNA. Thus, hypoxic HIF-1a protein activation
precedes its mRNA downregulation. The presence of a putative
HIF-1 binding site in the Hif1a exon I.2 58 flanking region,
which perfectly matched the tentative consensus sequence,4
opens the possibility that HIF-1 could downregulate HIF-1a
expression in an autoregulatory loop. Indeed, in the ARNT-
deficient subline Hepa1C4, known to be incapable of activating
hypoxia-responsive reporter genes,17,30 we observed no hypoxic
reduction in HIF-1a mRNA levels,30 supporting the hypothesis
of a feedback inhibition. However, deletion of this putative
HIF-1 binding site in the 232-bp exon I.2 upstream reporter
gene construct did not alter the hypoxic downregulation of
luciferase expression, suggesting that this putative HIF-1 bind-
ing site is not functional. Of note, a nonfunctional HIF-1
binding site is also present in the exon I.1 promoter,14 confirm-
ing that one such element in isolation is not sufficient to convey
hypoxic activation of gene expression.4 However, this result
cannot exclude that HIF-1 might be involved in the regulation
of its own expression.
In summary, the present report completes our work on the
two alternative mouse Hif1a promoters, establishes a housekeep-
ing-type major HIF-1a mRNA isoform corresponding to the
one known in humans, and opens intriguing questions on the
biological function(s) of the tissue-specific alternative mRNA
isoform.
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